FDA: Breast Implant Safety Studies Will Continue, Web MD, August 31, 2011

//FDA: Breast Implant Safety Studies Will Continue, Web MD, August 31, 2011

FDA: Breast Implant Safety Studies Will Continue, Web MD, August 31, 2011

Web MD reports the current post-approval studies on silicone-gel implants will continue according to the FDA’s Center for Devices and Radiological Health (CDRH) even though among the original 100,000 women enrolled in the studies, researchers have lost track of up to 79% of the women. That was just three years into a 10-year study.

William Maisel, MD and chief scientist at the CDRH said the studies will continue despite the fact that the studies have lost the ability to find complications such as connective tissue disease they were intended to find.

Read the rest of the story here.

By | 2011-09-03T03:06:26+00:00 September 3rd, 2011|Media Reports|0 Comments

About the Author:

I’m National News Editor, Jane Akre and I began Mesh Medical Device News Desk aka Mesh News Desk (MND) in the summer of 2011 just after the Food and Drug Administration issued an explicit warning to the public that complications associated with surgical mesh used for prolapse repair (POP) and incontinence (SUI) are NOT rare! That was the starting point for the litigation you see today and thousands of lawsuits have been filed by women whose lives have been altered, some permanently, by the use of this petroleum-based product.

Leave A Comment